Trial Profile
A retrospective study comparing coronary artery bypass graft and PCI using everolimus-eluting stent in patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 15 Sep 2015 Primary endpoint (All cause mortality) has not been met.
- 15 Sep 2015 Results published in the Journal of the American College of Cardiology.
- 15 Sep 2015 New trial record